These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1959395)
21. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
23. Comparison of captopril and enalapril in patients with severe chronic heart failure. Packer M; Lee WH; Yushak M; Medina N N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566 [TBL] [Abstract][Full Text] [Related]
24. [Acute reversible kidney insufficiency due to enalapril during diuretic-treated heart insufficiency]. Degenhardt S Dtsch Med Wochenschr; 1987 Jun; 112(24):960-3. PubMed ID: 3036457 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin converting enzyme inhibitor and chronic renal failure. Sitprija V; Lumlertgul D J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635 [TBL] [Abstract][Full Text] [Related]
26. Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure. Haffner CA; Kendall MJ; Struthers AD; Bridges A; Stott DJ Postgrad Med J; 1995 May; 71(835):287-92. PubMed ID: 7596934 [TBL] [Abstract][Full Text] [Related]
27. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Todd PA; Heel RC Drugs; 1986 Mar; 31(3):198-248. PubMed ID: 3011386 [TBL] [Abstract][Full Text] [Related]
28. [Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function]. Osterziel KJ; Dietz R; Mikulaschek K; Röhrig N; Schmid W; Manthey J; Kübler W Z Kardiol; 1988 Jun; 77(6):378-84. PubMed ID: 2850682 [TBL] [Abstract][Full Text] [Related]
29. Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. Anand IS; Kalra GS; Ferrari R; Wahi PL; Harris PC; Poole-Wilson PA Int J Cardiol; 1990 Sep; 28(3):341-6. PubMed ID: 2210899 [TBL] [Abstract][Full Text] [Related]
30. Comparison of hormonal and haemodynamic changes after long-term oral therapy with pimobendan or enalapril--a double-blind randomized study. Erlemeier HH; Kupper W; Bleifeld W Eur Heart J; 1991 Aug; 12(8):889-99. PubMed ID: 1915427 [TBL] [Abstract][Full Text] [Related]
31. [Efficacy of long-term treatment with enalapril in patients with congestive heart failure]. Cannavà G; Buttafarro A; Mangano A; Silipigni C; Cordiani A; Casella F; Pavia L Cardiologia; 1990 Jun; 35(6):485-7. PubMed ID: 2127733 [TBL] [Abstract][Full Text] [Related]
32. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency. Giri S; Mahajan SK; Sen R; Sharma A J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207 [TBL] [Abstract][Full Text] [Related]
33. High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. Fyhrquist F; Karppinen K; Honkanen T; Saijonmaa O; Rosenlöf K J Intern Med; 1989 Oct; 226(4):257-60. PubMed ID: 2553845 [TBL] [Abstract][Full Text] [Related]
34. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507 [TBL] [Abstract][Full Text] [Related]
35. [Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril]. Hess B; Keusch G; Neftel K; Margelist F; Bansky G Schweiz Med Wochenschr; 1986 Sep; 116(39):1331-6. PubMed ID: 3022372 [TBL] [Abstract][Full Text] [Related]
36. The use of enalapril in the treatment of feline hypertrophic cardiomyopathy. Rush JE; Freeman LM; Brown DJ; Smith FW J Am Anim Hosp Assoc; 1998; 34(1):38-41. PubMed ID: 9527429 [TBL] [Abstract][Full Text] [Related]
37. Clinical experience with lisinopril in congestive heart failure. Focus on the older patient. Giles TD Drugs; 1990; 39 Suppl 2():17-22. PubMed ID: 2160883 [TBL] [Abstract][Full Text] [Related]
38. Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure. Todd PA; Goa KL Drugs; 1989 Feb; 37(2):141-61. PubMed ID: 2539290 [TBL] [Abstract][Full Text] [Related]
39. Enalapril improved renal function and proteinuria in chronic glomerulopathies. Ferder LF; Inserra F; Daccordi H; Smith RD Nephron; 1990; 55 Suppl 1():90-5. PubMed ID: 2345596 [TBL] [Abstract][Full Text] [Related]
40. Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure. Pomini G; Gribaldo R; Rugna A; Lupia M; Molfese G; Carenza P G Ital Cardiol; 1991 Jan; 21(1):59-65. PubMed ID: 2055378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]